thanks mate. So you just proved Zecs and Hawk70 both wrong
They spent 6 years helping them de risk safety preclinical. Hence the probability of safety success is very high hence why they raised at 12 cents. This isn’t a 14 million dollar market cap and will still become a 100 million dollar plus company on safety tick off.
It’s running either way so hence why I bought more.
The drug is a 3 in 1 treatment for stroke and heart muscle protection. It surpasses the efforts of AGN. There is nothing out there like it in the world. This will rerate and the time will come shortly
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)